190 related articles for article (PubMed ID: 12644441)
1. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney.
Gui Y; Loutzenhiser R; Hollenberg MD
Am J Physiol Renal Physiol; 2003 Jul; 285(1):F95-104. PubMed ID: 12644441
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
Huang SC
Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
[TBL] [Abstract][Full Text] [Related]
3. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
[TBL] [Abstract][Full Text] [Related]
4. PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions.
Trottier G; Hollenberg M; Wang X; Gui Y; Loutzenhiser K; Loutzenhiser R
Am J Physiol Renal Physiol; 2002 May; 282(5):F891-7. PubMed ID: 11934700
[TBL] [Abstract][Full Text] [Related]
5. Proteinase-activated receptor-1 (PAR1) and PAR2 mediate relaxation of guinea pig internal anal sphincter.
Huang SC
Regul Pept; 2014 Feb; 189():46-50. PubMed ID: 24631471
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptors 1 and 2 exert opposite effects on renal renin release.
Höcherl K; Gerl M; Schweda F
Hypertension; 2011 Oct; 58(4):611-8. PubMed ID: 21859963
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor 4 (PAR4): action of PAR4-activating peptides in vascular and gastric tissue and lack of cross-reactivity with PAR1 and PAR2.
Hollenberg MD; Saifeddine M; Al-Ani B; Gui Y
Can J Physiol Pharmacol; 1999 Jun; 77(6):458-64. PubMed ID: 10537233
[TBL] [Abstract][Full Text] [Related]
8. Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric artery.
Kawabata A; Kubo S; Nakaya Y; Ishiki T; Kuroda R; Sekiguchi F; Kawao N; Nishikawa H
Cardiovasc Res; 2004 Mar; 61(4):683-92. PubMed ID: 14985065
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2.
McGuire JJ; Dai J; Andrade-Gordon P; Triggle CR; Hollenberg MD
J Pharmacol Exp Ther; 2002 Dec; 303(3):985-92. PubMed ID: 12438518
[TBL] [Abstract][Full Text] [Related]
10. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity.
Roy SS; Saifeddine M; Loutzenhiser R; Triggle CR; Hollenberg MD
Br J Pharmacol; 1998 Apr; 123(7):1434-40. PubMed ID: 9579740
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.
Saifeddine M; Roy SS; Al-Ani B; Triggle CR; Hollenberg MD
Br J Pharmacol; 1998 Dec; 125(7):1445-54. PubMed ID: 9884072
[TBL] [Abstract][Full Text] [Related]
12. Effect of protease-activated receptor (PAR)-1, -2 and -4-activating peptides, thrombin and trypsin in rat isolated airways.
Chow JM; Moffatt JD; Cocks TM
Br J Pharmacol; 2000 Dec; 131(8):1584-91. PubMed ID: 11139435
[TBL] [Abstract][Full Text] [Related]
13. Proteinase activated receptor 2: Role of extracellular loop 2 for ligand-mediated activation.
Al-Ani B; Saifeddine M; Kawabata A; Hollenberg MD
Br J Pharmacol; 1999 Nov; 128(5):1105-13. PubMed ID: 10556949
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
[TBL] [Abstract][Full Text] [Related]
15. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
Glusa E; Saft A; Prasa D; Stürzebecher J
Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of trypsin-induced contraction in the rat myometrium: the possible involvement of a novel member of protease-activated receptor.
Shintani Y; Hirano K; Nakayama T; Nishimura J; Nakano H; Kanaide H
Br J Pharmacol; 2001 Aug; 133(8):1276-85. PubMed ID: 11498513
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
[TBL] [Abstract][Full Text] [Related]
20. Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells.
Greenberg DL; Mize GJ; Takayama TK
Biochemistry; 2003 Jan; 42(3):702-9. PubMed ID: 12534282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
